Scientists continue to explore ways we can live longer and ensure those lives are healthier. A new discovery of note in this field comes from experiments in fission yeast (an organism often used for ...
Add Yahoo as a preferred source to see more of our stories on Google. The team found that a drug called Rapalink-1, already under investigation for cancer therapy, extends lifespan. (CREDIT: ...
Researchers at Queen Mary University of London’s School of Biological and Behavioural Sciences, using the simple fission yeast as a model, have shown that a new target of rapamycin (TOR) inhibitor, ...
Scientists have identified a new anti-ageing drug class that works by acting on a key gut bacteria process, an advance that may lead to ways to prolong lifespan in humans. Researchers from Queen Mary ...
Researchers from Queen Mary University of London’s School of Biological and Behavioural Sciences, using the simple fission yeast as a model, have shown that new TOR inhibitor rapalink-1 prolongs ...
Researchers from Queen Mary University of London's School of Biological and Behavioural Sciences, using the simple fission yeast as a model, have shown that new TOR inhibitor rapalink-1 prolongs ...
A recent study conducted by researchers at Queen Mary University of London unveiled a new mechanism through which cells control aging. With simple fission yeast, the scientists showed that Rapalink-1, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results